Jonah B. Sacha, Ph.D.
- Professor, Oregon National Primate Research Center
- Professor, VGTI-Vaccine and Gene Therapy Institute
- Molecular Microbiology and Immunology Graduate Program, School of Medicine
- Program in Molecular and Cellular Biosciences, School of Medicine
Biography
Dr. Sacha graduated cum laude from the University of Missouri-Columbia in 2003 with a B.A. in German and B.S. in Biology. After receiving his Ph.D. in Medical Microbiology & Immunology from the University of Wisconsin-Madison in 2007, he joined the Oregon Health & Science University with appointments in both the Oregon National Primate Research Center and the Vaccine & Gene Therapy Institute in 2011. In 2023 he became Chief of the Division of Pathobiology and Immunology. He maintains a translational-focused research program that has included research on endogenous retroviruses (ERVs), Hepatitis B virus (HBV), Yellow Fever Virus (YFV), SARS-CoV-2 (COVID19), Long COVID, Monkeypox (MPOX), Cytomegalovirus (CMV), Mycobacterium Tuberculosis (MTB), allogeneic stem cell transplantation (alloSCT), and re-emerging pathogens like Oropouche Virus (OROV).
Education and training
-
Degrees
- B.S., 2003, University of Missouri
- Ph.D., 2007, University of Wisconsin
Memberships and associations:
- Member, American Society of Microbiology
- Member, Society for Leukocyte Biology
- Member, International AIDS Society
- Member, American Society of Hematology
Areas of interest
- T cell Biology
- Retroviruses
- Vaccine development
- Cell and Gene Therapy
Honors and awards
- 2013 - Creative and Novel Ideas in HIV Research Award
- 2011 - AIDS Vaccine Conference Scholarship Award
- 2011 - Young Investigator Editor for AIDS Research & Human Retroviruses
- 2008 - Nonhuman Primate Symposium Young Investigator Scholarship
- 2008 - University of Wisconsin-Madison Vilas Travel Scholarship
- 2007 - Keystone Symposia: HIV Vaccines Young Investigator Scholarship
- 2003 - National Science Foundation REU Graduate Fellowship
- 2003 - Bachelor of Science with Departmental Honors
- 2003 - Bachelor of Science with Honors, cum laude
- 2003 - Bachelor of Arts with Honors, cum laude
- 1997 - Rotary International Youth Ambassador to Germany
- 1997 - Bright Flight Undergraduate Scholarship (maintained all years at University of Missouri)
Publications
Publications
Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes
Proceedings of the National Academy of Sciences of the United States of AmericaA model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques
PLoS pathogensA Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
Clinical therapeuticsCytomegalovirus vaccine vector-induced effector memory CD4 + T cells protect cynomolgus macaques from lethal aerosolized heterologous avian influenza challenge
Nature communicationsEffect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primates
JCI InsightFcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
mAbsHuman cytomegalovirus UL18 prevents priming of MHC-E– and MHC-II–restricted CD8+ T cells
Science ImmunologyImmune perturbation following SHIV infection is greater in newborn macaques than in infants
JCI InsightImmune restoration by TIGIT blockade is insufficient to control chronic SIV infection
Journal of virologyKDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells
Antiviral ResearchSequence Analysis of microRNAs Encoded by Simian Lymphocryptoviruses
VirusesViral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques
Frontiers in immunologyAllogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques
ImmunityIdentification of Vancomycin Resistance in Methicillin-resistant Staphylococcus aureus in two macaque species and decolonization and long-term prevention of recolonization in Cynomolgus Macaques (Macaca fascicularis)
Frontiers in immunologyTherapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection
Science translational medicineVector-Mediated Delivery of Human Major Histocompatibility Complex-I into Hepatocytes Enables Investigation of T Cell Receptor-Redirected Hepatitis B Virus-Specific T Cells in Mice, and in Macaque Cell Cultures
Human Gene TherapyCytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species
Cell Host and MicrobeLong-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
Nature communicationsOptimization and use of near infrared imaging to guide lymph node collection in rhesus macaques (Macaca mulatta)
Journal of medical primatologyPandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques
Journal of virologyReduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome
Clinical Infectious DiseasesReply to Viel
Clinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaSuppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
PLoS pathogensAntibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
Nature communicationsCCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14
International Journal of Infectious DiseasesCCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
Frontiers in immunologyClinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
Clinical Infectious DiseasesCytomegaloviral determinants of CD8+T cell programming and RhCMV/SIV vaccine efficacy
Science Immunology